Corton Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-575
Closed -$509K 521
2024
Q3
$509K Buy
575
+340
+145% +$306K 0.25% 53
2024
Q2
$213K Sell
235
-2,308
-91% -$1.85M 0.11% 335
2024
Q1
$1.98M Sell
2,543
-1,026
-29% -$730K 0.73% 4
2023
Q4
$2.08M Buy
3,569
+1,162
+48% +$678K 0.66% 6
2023
Q3
$1.29M Sell
2,407
-128
-5% -$66K 0.65% 9
2023
Q2
$1.19M Buy
2,535
+778
+44% +$326K 0.56% 12
2023
Q1
$603K Buy
1,757
+288
+20% +$97.1K 0.42% 36
2022
Q4
$537K Buy
1,469
+448
+44% +$159K 0.44% 47
2022
Q3
$330K Sell
1,021
-1,023
-50% -$324K 0.4% 89
2022
Q2
$663K Sell
2,044
-855
-29% -$257K 0.63% 31
2022
Q1
$830K Buy
+2,899
New +$746K 0.36% 47

Other funds holding LLY

Corton Capital's LLY Position: Q4 2024 in Review

Corton Capital sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 575 shares — an estimated $509K sold.

Corton Capital first reported a position in LLY in Q1 2022 and held it in 11 quarters. The position peaked at $2.08M in Q4 2023. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Corton Capital reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • Corton Capital sold 575 Eli Lilly shares in Q4 2024, an estimated $509K.
  • Corton Capital first reported a position in Eli Lilly in Q1 2022 and held it in 11 quarters.
  • Corton Capital's Eli Lilly position peaked at $2.08M in Q4 2023.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Corton Capital's 13F filing for Q4 2024, filed 14 Feb 2025.